ALT•benzinga•
What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday?
Summary
Pfizer ends danuglipron development after liver safety issue, boosting shares of Viking, Eli Lilly, and Novo Nordisk amid obesity drug competition.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 14, 2025 by benzinga